|
Market Closed -
Nasdaq
21:00:00 14/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 505.75 USD | -2.07% |
|
+1.95% | +11.56% |
| 08-12 | Vertex Has Multiple Portfolio Catalysts With Favorable Risk-Reward, RBC Says | MT |
| 08-11 | Jefferies Adjusts Price Target on Vertex Pharmaceuticals to $633 From $610, Maintains Buy Rating | MT |
Chart: Technical Analysis
Stock exchange
Nasdaq
VRTX 505.75 $
-2.07%
572M
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
Nasdaq
| VRTX | 505.75USD | -2.07% | 572M $ | |
CBOE
| VRTX | 505.35USD | -2.11% | 13.51M $ | |
|
Mexican S.E.
| VRTX * | 8,648.36MXN | -3.44% | 7.44M $ | |
|
Tradegate
| VX1 | 436.90EUR | -2.47% | 210K € | |
|
Xetra
| VX1 | 437.40EUR | -3.70% | 29.74K € | |
|
Boerse Muenchen
| VX1 | 437.20EUR | -2.47% | 11.8K € | |
|
London S.E.
| 0QZU | 526.81USD | +4.79% | 12.12K $ | |
|
Deutsche Boerse AG
| VX1 | 438.85EUR | -3.45% | 8.78K € | |
|
Börse Stuttgart
| VX1 | 436.35EUR | -2.74% | 4.36K € | |
|
Wiener Boerse
| VRTX | 438.15EUR | -3.55% | 0 € | |
|
Borsa Italiana
| 1VRTX | 437.70EUR | -3.70% | 0 € | |
|
CBOE
| 0QZU | 459.80EUR | 0.00% | 0 € | |
|
CBOE
| 452.95EUR | 0.00% | 0 € | ||
Sao Paulo
| VRTX34 | 83.28BRL | -85.63% | 9.33K R$ | |
Buenos Aires S.E.
| VRTX | 7,860.00ARS | -2.78% | 7.18M $ | |
|
Buenos Aires S.E.
| VRTXD | 5.250USD | -0.76% | 593.25 $ |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Bullish |
| Resistance | 529.65 | 529.65 | 528.04 |
| Spread/Res. | -4.51% | -4.51% | -4.22% |
| Spread/Supp. | +1.22% | +7.44% | +13.01% |
| Support | 499.65 | 470.72 | 447.54 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- VRTX Stock
- Charts Vertex Pharmaceuticals Incorporated
Select your edition
All financial news and data tailored to specific country editions
